CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 190 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210,337 | -19.1% | 4,634 | +0.0% | 0.00% | – |
| Q2 2023 | $260,040 | -31.5% | 4,632 | -44.8% | 0.00% | – |
| Q1 2023 | $379,524 | +100.1% | 8,391 | +79.8% | 0.00% | – |
| Q4 2022 | $189,714 | +287.2% | 4,667 | +528.1% | 0.00% | – |
| Q3 2022 | $49,000 | -99.3% | 743 | -99.4% | 0.00% | -100.0% |
| Q2 2022 | $7,529,000 | -3.4% | 123,892 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $7,790,000 | +3854.3% | 124,090 | +4663.5% | 0.00% | – |
| Q4 2021 | $197,000 | -40.5% | 2,605 | -11.8% | 0.00% | – |
| Q3 2021 | $331,000 | -51.5% | 2,954 | -30.0% | 0.00% | – |
| Q2 2021 | $683,000 | -92.9% | 4,217 | -94.6% | 0.00% | -100.0% |
| Q1 2021 | $9,575,000 | -61.2% | 78,582 | -51.3% | 0.01% | -66.7% |
| Q4 2020 | $24,692,000 | +450.9% | 161,266 | +201.0% | 0.02% | +400.0% |
| Q3 2020 | $4,482,000 | +3.2% | 53,585 | -9.3% | 0.00% | 0.0% |
| Q2 2020 | $4,344,000 | +3241.5% | 59,103 | +1833.4% | 0.00% | – |
| Q1 2020 | $130,000 | -98.4% | 3,057 | -97.7% | 0.00% | -100.0% |
| Q4 2019 | $8,169,000 | +440.3% | 134,140 | +263.6% | 0.01% | +400.0% |
| Q3 2019 | $1,512,000 | +7100.0% | 36,896 | +7651.3% | 0.00% | – |
| Q2 2019 | $21,000 | +31.2% | 476 | +1.9% | 0.00% | – |
| Q1 2019 | $16,000 | -89.3% | 467 | -91.2% | 0.00% | – |
| Q4 2018 | $150,000 | -50.5% | 5,285 | -22.7% | 0.00% | – |
| Q3 2018 | $303,000 | -98.4% | 6,840 | -97.8% | 0.00% | -100.0% |
| Q2 2018 | $18,673,000 | +1574.7% | 317,820 | +1200.7% | 0.01% | +400.0% |
| Q1 2018 | $1,115,000 | -18.4% | 24,435 | -58.1% | 0.00% | 0.0% |
| Q4 2017 | $1,367,000 | +170.2% | 58,265 | +105.3% | 0.00% | – |
| Q3 2017 | $506,000 | +6225.0% | 28,384 | +5576.8% | 0.00% | – |
| Q2 2017 | $8,000 | -94.7% | 500 | -92.8% | 0.00% | – |
| Q1 2017 | $150,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |